Results 1 to 10 of about 1,688,643 (309)

Assessment and validation of the TREAT-B score to assess the treatment eligibility of patients with chronic hepatitis B virus infection

open access: yesFrontiers in Medicine, 2022
Background and aimsAccess to Hepatitis B virus (HBV) DNA testing to determine treatment eligibility is limited in low-income countries. Therefore, this study aimed to assess and validate the TREAT-B score proposed as the treatment threshold in an Asian ...
Kessarin Thanapirom   +13 more
doaj   +1 more source

Combi-Elasto Evaluation of the Degree of Liver Fibrosis in Children with Cholestatic Liver Disease

open access: yesDiagnostics, 2023
Cholestatic liver disease is a common liver disease in infants and young children. Liver fibrosis is a key factor affecting the prognosis, and liver transplantation is the only treatment option for liver cirrhosis.
Rina Li   +8 more
doaj   +1 more source

The role of hepatic microenvironment in hepatic fibrosis development

open access: yesAnnals of Medicine, 2022
Aim Fibrosis is a common pathological feature of most types of chronic liver injuries. There is no specific treatment for liver fibrosis at present. The liver microenvironment, which fosters the survival and activity of liver cells, plays an important ...
Ying Meng   +3 more
doaj   +1 more source

GDF15 Ameliorates Liver Fibrosis by Metabolic Reprogramming of Macrophages to Acquire Anti-Inflammatory PropertiesSummary

open access: yesCellular and Molecular Gastroenterology and Hepatology, 2023
Background & Aims: Liver fibrosis/cirrhosis is significant health burden worldwide, resulting in liver failure or cancer and accounting for many deaths each year.
Xiaolei Li   +6 more
doaj   +1 more source

Cirrhotic Human Liver Extracellular Matrix 3D Scaffolds Promote Smad-Dependent TGF-β1 Epithelial Mesenchymal Transition

open access: yesCells, 2019
An altered liver microenvironment characterized by a dysregulated extracellular matrix (ECM) supports the development and progression of hepatocellular carcinoma (HCC). The development of experimental platforms able to reproduce these physio-pathological
Giuseppe Mazza   +26 more
doaj   +1 more source

The Determinants of Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus

open access: yesBiomedicines, 2022
Liver fibrosis is a key pathophysiology process in chronic liver disease. It is still unclear whether the impact of liver fibrosis is not fully realized in type 2 diabetes mellitus (T2D) patients with nonalcoholic fatty liver disease (NAFLD), and the ...
Chia-Yen Dai   +4 more
doaj   +1 more source

Comparison of MR-PWI quantitative and semi-quantitative parameters for the evaluation of liver fibrosis

open access: yesBMC Medical Imaging, 2021
Background To evaluate different stages of liver fibrosis in cynomolgus monkeys by comparing magnetic resonance-perfusion weighted imaging (MR-PWI) quantitative and semi-quantitative parameters, and confirm the best detection indicators for diagnosis of ...
Ke Ding   +7 more
doaj   +1 more source

The roles and mechanisms of hypoxia in liver fibrosis

open access: yesJournal of Translational Medicine, 2021
Liver fibrosis occurs in response to any etiology of chronic liver injury. Lack of appropriate clinical intervention will lead to liver cirrhosis or hepatocellular carcinoma (HCC), seriously affecting the quality of life of patients, but the current ...
Jingyao Cai   +3 more
doaj   +1 more source

Novel Therapeutic Targets in Liver Fibrosis

open access: yesFrontiers in Molecular Biosciences, 2021
Liver fibrosis is end-stage liver disease that can be rescued. If irritation continues due to viral infection, schistosomiasis and alcoholism, liver fibrosis can progress to liver cirrhosis and even cancer.
Jinhang Zhang   +4 more
doaj   +1 more source

Combined evaluation of Fibrosis‐4 index and fatty liver for stratifying the risk for diabetes mellitus

open access: yesJournal of Diabetes Investigation, 2022
Aims/Introduction To investigate whether the Fibrosis‐4 index can help stratify the risk of diabetes mellitus in patients with fatty liver disease.
Yasuhiko Todo   +19 more
doaj   +1 more source

Home - About - Disclaimer - Privacy